Juan Andres Moderna, Inc. (MRNA) insider trading activity

Juan Andres is Officer of Moderna, Inc.. Currently has a direct ownership of 12,803 shares of MRNA, which is worth approximately $471,790. The most recent transaction as insider was on Aug 17, 2022, when has been sold 2,000 shares (Common Stock) at a price of $165.24 per share, resulting in proceeds of $330,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

0% 3M change

0% 12M change

Total Value Held $471,790

Juan Andres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 17 2022	SELL Open market or private sale	$330,480 $165.24 p/Share	2,000 Reduced 15.88%	10,598 Common Stock
Aug 17 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.7%	12,598 Common Stock
Aug 10 2022	SELL Open market or private sale	$383,232 $173.88 p/Share	2,204 Reduced 17.22%	10,598 Common Stock
Aug 10 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.7%	12,598 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	-	435 Added 3.87%	10,802 Common Stock
Aug 03 2022	SELL Open market or private sale	$335,980 $167.99 p/Share	2,000 Reduced 16.17%	10,367 Common Stock
Aug 03 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.92%	12,367 Common Stock
Jul 27 2022	SELL Open market or private sale	$322,000 $161.0 p/Share	2,000 Reduced 16.17%	10,367 Common Stock
Jul 27 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.92%	12,367 Common Stock
Jul 20 2022	SELL Open market or private sale	$334,000 $167.0 p/Share	2,000 Reduced 16.17%	10,367 Common Stock
Jul 20 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.92%	12,367 Common Stock
Jul 13 2022	SELL Open market or private sale	$337,760 $168.88 p/Share	2,000 Reduced 16.17%	10,367 Common Stock
Jul 13 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.92%	12,367 Common Stock
Jul 06 2022	SELL Open market or private sale	$309,700 $154.85 p/Share	2,000 Reduced 16.17%	10,367 Common Stock
Jul 06 2022	BUY Exercise of conversion of derivative security	$41,860 $20.93 p/Share	2,000 Added 13.92%	12,367 Common Stock
Jul 01 2022	SELL Open market or private sale	$900,000 $150.0 p/Share	6,000 Reduced 36.66%	10,367 Common Stock
Jul 01 2022	BUY Exercise of conversion of derivative security	$125,580 $20.93 p/Share	6,000 Added 26.83%	16,367 Common Stock
Jun 08 2022	SELL Open market or private sale	$1,500,000 $150.0 p/Share	10,000 Reduced 49.1%	10,367 Common Stock
Jun 08 2022	BUY Exercise of conversion of derivative security	$198,100 $19.81 p/Share	10,000 Added 32.93%	20,367 Common Stock
May 31 2022	SELL Open market or private sale	$108,905 $145.4 p/Share	749 Reduced 6.74%	10,367 Common Stock
May 27 2022	BUY Exercise of conversion of derivative security	$245,391 $135.8 p/Share	1,807 Added 13.98%	11,116 Common Stock
May 10 2022	SELL Open market or private sale	$26,073 $133.71 p/Share	195 Reduced 2.05%	9,309 Common Stock
May 09 2022	BUY Exercise of conversion of derivative security	$58,464 $134.4 p/Share	435 Added 4.38%	9,504 Common Stock
May 04 2022	SELL Open market or private sale	$306,460 $153.23 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
May 04 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock

Also insider at

AVTR

Avantor, Inc. Basic Materials

Director

EVLO

Evelo Biosciences, Inc. Healthcare

Director

Juan Andres

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account